Back to today’s briefing

Story perspectives

17 Million Youths Face Diabetes Risk Without Care

8/6/2025

45 10

Summary

Story summary

Almost 17 million young Americans could benefit from GLP-1 receptor agonists to combat type 2 diabetes and obesity. Yet, a lack of insurance and healthcare access stands in their way, leaving them vulnerable to serious health issues. Experts urge for better coverage and accessibility to safeguard the well-being of our youth.

1 of 1

Story summary

Almost 17 million young Americans could benefit from GLP-1 receptor agonists to combat type 2 diabetes and obesity. Yet, a lack of insurance and healthcare access stands in their way, leaving them vulnerable to serious health issues. Experts urge for better coverage and accessibility to safeguard the well-being of our youth.